The chikungunya virus, transmitted by Aedes aegypti and Aedes albopictus mosquitoes and responsible for more than 900 deaths in Brazil since it arrived around ten years ago, is capable of spreading through the blood, reaching ...
Mar 12, 2024
0
23
People infected with the chikungunya virus (CHIKV) still have an increased risk of death from complications for up to three months post-infection, according to new research published in The Lancet Infectious Diseases.
Feb 13, 2024
0
21
Analysis of occurrence and co-occurrence patterns shows the highest-risk clusters of chikungunya and Zika in Brazil spreading from the Northeast to the Center-West and coastal areas of São Paulo state and Rio de Janeiro ...
Jan 17, 2024
0
1
The chikungunya virus is widespread in tropical regions, where it is spread to humans by mosquitoes of the genus Aedes. Chikungunya is characterized by high fever, headache, muscle and joint pain, rash, and sometimes diarrhea. ...
Nov 22, 2023
0
0
US health authorities on Thursday approved the world's first vaccine for chikungunya, a virus spread by infected mosquitoes that the Food and Drug Administration called "an emerging global health threat."
Nov 10, 2023
0
13
Underlying evolutionary dynamics could play a key role in the replication and progress of the chikungunya virus, a mosquito-borne viral disease. New research from Ph.D. student Wern Hann Ng, Dr. Xiang Liu and Professor Suresh ...
Oct 27, 2023
0
27
Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves within cells. But by mimicking ...
Aug 2, 2023
0
1
Peruvoside, a plant-based compound that is commonly used to treat heart failure, has been discovered to be able to prevent up to 12 medically important viruses, all originating from different virus families. These viruses ...
Jun 22, 2023
0
9
European Union officials warned Thursday there is a growing risk of mosquito-borne viral diseases such as dengue and chikungunya in Europe due to climate change.
Jun 22, 2023
0
20
The VLA1553 vaccine candidate for chikungunya disease was generally well tolerated and produced an immune response in 99% (263/266) of participants, according to a phase 3 randomized controlled trial published in The Lancet.
Jun 12, 2023
0
40
Chikungunya (in the Makonde language "that which bends up") virus (CHIKV) is an insect-borne virus, of the genus Alphavirus, that is transmitted to humans by virus-carrying Aedes mosquitoes. There have been recent breakouts of CHIKV associated with severe illness. CHIKV infection causes an illness with symptoms similar to dengue fever, with an acute febrile phase of the illness lasting only two to five days, followed by a prolonged arthralgic disease that affects the joints of the extremities. The pain associated with CHIKV infection of the joints persists for weeks or months, or in some cases years.
This text uses material from Wikipedia, licensed under CC BY-SA
